Login to Your Account



Advancing Three Cancer Drugs, Salmedix Takes Aim At $86M IPO

By Karen Pihl-Carey


Tuesday, April 27, 2004
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription